GLP-1 receptor agonists are injectable medications that stimulate insulin secretion, suppress glucagon, slow gastric emptying, and reduce appetite through glucose-dependent mechanisms
Studied in advanced metabolic research models examining integrated hormonal pathway signaling
Conclusions This open-label, single-center pilot study suggests that GLP-1-RAs are an effective and safe treatment option for achieving significant weight loss with a favorable effect on headache, leading to reduced acetazolamide dosage in pwIIH
However, human studies are limited, and clinical significance remains uncertain compared to lifestyle interventions
Nevertheless, aim for 8-10 cups (64-80 ounces) of water daily
If your insurance covers weight management medications, a prescription is a straightforward first step